Aenitis Technologies Receives €4 Million in Funding from the European H2020 / SME Instrument Programme, for Its ABC-S’ Project (Acoustic Blood Cell Sorter)

PARIS--(BUSINESS WIRE)--Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industri

Full Story →